Diabetes, prediabetes linked to heavier menopause symptom burden

Clinical takeaway: Ask midlife women with type 2 diabetes or prediabetes about menopause symptoms, particularly after menopause, and address symptom burden as part of routine diabetes care.

Hot flashes, sleep problems, mood changes, and physical symptoms can make midlife harder even before they are layered onto the demands of diabetes management. When both are present, the combined burden can affect how women feel, function, and experience their health.

That overlap deserves attention because menopause symptoms may not fit neatly into a diabetes-focused visit. Looking beyond glucose control can reveal concerns that affect quality of life and warrant care in their own right.

Most prior research has focused on menopause timing or stage, leaving the overall symptom burden less clear. A cross-sectional study of nearly 300 midlife women evaluated whether diabetes or prediabetes was associated with more numerous and more severe menopause symptoms.

Women with type 2 diabetes or prediabetes reported an average of 20.3 menopause symptoms, compared with 15.9 among women without either condition. Their mean symptom-severity score was 36.5 versus 26.1.

Among menopause-stage subgroups, only the postmenopausal comparisons were statistically significant. Postmenopausal women with diabetes or prediabetes reported 19.2 versus 13.6 symptoms and severity scores of 33.8 versus 21.9. The associations persisted after adjustment, although diabetes or prediabetes status added just 1.4% and 1.0% to the explained variation in symptom number and severity, respectively.

The study used an online survey conducted in April and May 2024 among women ages 45 to 64 in South Korea. Fasting glucose and A1c criteria defined the type 2 diabetes or prediabetes group, and researchers measured menopause symptom number and severity before adjusting for selected background and health characteristics.

The postmenopausal finding identifies where the association was clearest, but it should not narrow attention to that stage alone. Symptom burden was numerically higher across all menopause stages, and imbalances in subgroup size may have made smaller differences harder to detect.

“This study demonstrates that women with diabetes may experience a greater burden of menopause symptoms. Prior research has also shown that cardiovascular risk factors, including diabetes, hypertension, and dyslipidemia, are associated with more frequent vasomotor symptoms, and women with a higher vasomotor symptom burden tend to have a less favorable cardiometabolic risk profile,” said Stephanie Faubion, medical director for The Menopause Society.

She concluded, "Together, these findings not only highlight the need to recognize and address menopause symptoms in women with diabetes but also underscore the menopause transition as an important opportunity to identify and manage cardiovascular risk factors in all women.”

Source: Yang, et al. (2026 Aug 5) Menopause. Association between type 2 diabetes mellitus and menopausal symptoms among Korean midlife women